TRTP 101
Alternative Names: TRTP-101Latest Information Update: 13 Feb 2024
At a glance
- Originator Cell in Cells
- Class Stem cell therapies
- Mechanism of Action Tissue replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Scars
Most Recent Events
- 06 Dec 2023 Phase-I clinical trials in Scars in South Korea (Parenteral) (NCT06210919)